Menopause and risk of non-fatal acute myocardial infarction: An Italian case-control study and a review of the literature

Human Reproduction

Volumn 15, Issue 3, 2000, Pages 599-603

  Fioretti, Francesca ^a   Tavani, Alessandra ^a   Gallus, Silvano ^a   Franceschi, Silvia ^b   La Vecchia, Carlo ^a,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Acute myocardial infarction; Case control study; Menopause; Risk factors

Indexed keywords

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; DISEASE ASSOCIATION; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENOPAUSE; RISK FACTOR; SMOKING HABIT;

EID: 0034008904     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.3.599     Document Type: Article

References (42)

1. Barrett-Connor, E. (1998) Hormone replacement therapy. Br. Med. J., 317, 457-461.
2. Barrett-Connor, E. and Bush, T.L. (1991) Estrogen and coronary heart disease in women. JAMA, 265, 1861-1867.
3. Bean, J.A., Leeper, J.D., Wallace, R.B. et al. (1979) Variations in the reporting of menstrual histories. Am. J. Epidemiol., 109, 181-185.
4. Breslow, N.E. and Day, N.E. (1980) Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies. IARC Scientific Publication no. 32.
5. Colditz, G.A., Willett, W.C., Stampfer, M.J. et al. (1987) Menopause and the risk of coronary heart disease in women. N. Engl. J. Med., 316, 1105-1110.
6. Cooper, G.S. and Sandler, D.P. (1998) Age at natural menopause and mortality. Ann. Epidemiol., 8, 229-235.
7. Cooper, G.S., Ephross, S.A., Weinberg, C.R. et al. (1999) Menstrual and reproductive risk factors for ischemic heart disease. Epidemiology, 10, 255-259.
8. Dallongeville, J., Marecaux, N., Isorez, D. et al. (1995) Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis, 118, 123-133.
9. Daly E., Vessey, M.P., Hawkins, M.M. et al. (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet, 348, 977-980.
10. D'Avanzo, B., La Vecchia, C., Katsouyanni, K. et al. (1997) An assessment, and reproducibility of food frequency data provided by hospital controls. Eur. J. Cancer Prev., 6, 288-293.
11. Davis, C.E., Pajak, A., Rywik, S. et al. (1994) Natural menopause and cardioascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Ann. Epidemiol., 4, 445-448.
12. Gensini, G.F, Comeglio, M. and Colella A. (1998) Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur. Heart J., 19, Suppl. A, A53-A61.
13. Gordon, T., Kannel, W.B., Hjortland, M.C. and McNamara, P.M. (1978) Menopause and coronary heart disease. The Framingham Study. Ann. Intern. Med., 89, 157-161.
14. Greendale, G.A., Lee, N.P. and Arriola, E.R. (1999) The menopause. Lancet, 353, 571-580.
15. Grodstein, F., Stampfer, M.J., Manson, J.E. et al. (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med., 335, 453-461.
16. Hazzard, W.H. (1989) Estrogen replacement and cardiovascular disease: serum lipids and blood pressure effects. Am. J. Obstet. Gynecol., 161, 1847-1853.
17. Heller, R.F. and Jacobs, H.S. (1978) Coronary heart disease in relation to age, sex, and the menopause. Br. Med. J., 1, 472-474.
18. Hemminki, E. and McPherson, K. (1997) Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. Br. Med. J., 315, 149-153.
19. Hulley, S., Grady, D., Bush, T. et al. for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA, 280, 605-613.
20. Jacobsen, B.K., Nilssen, S., Heuch, I. et al. (1997) Does age at natural menopause affect mortality from ischemic heart disease? J. Clin. Epidemiol., 50, 475-479.
21. Jacobsen, B.K., Knutsen S.F. and Fraser, G.E. (1999) Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J. Clin. Epidemiol., 52, 303-307.
22. Jick, H., Derby, L.E., Myers, M.W. et al. (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet, 348, 981-983.
23. Kannel, W.B., Hjortland, M.C., McNamara, P.M. et al. (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann. Intern. Med., 85, 447-452.
24. La Vecchia, C. (1992) Sex hormones and cardiovascular risk. Hum. Reprod., 7, 162-167.
25. La Vecchia, C., Decarli, A., Franceschi, S. et al. (1987a) Menstrual and reproductive factors and the risk of myocardial infarction in women under fifty-five years of age. Am. J. Obstet. Gynecol., 157, 1108-1112.
26. La Vecchia, C., Franceschi, S., Decarli, A. et al. (1987b) Risk factors for myocardial infarction in young women. Am. J. Epidemiol., 125, 832-843.
27. La Vecchia, C., Gentile, A., Negri, E. et al. (1989) Coffee consumption and myocardial infarction in women. Am. J. Epidemiol., 130, 481-485.
28. Lapidus, L., Bengtsson, C. and Lindquist, O. (1985) Menopausal age and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Obstet. Gynecol. Scand., Suppl. 130, 37-41.
29. Lloyd-Jones, D.M., Larson, M.G., Beiser, A. et al. (1999) Lifetime risk of developing coronary heart disease. Lancet, 353, 89-92.
30. McCrohon, J.A., Adams, M.R., McCredie, R.J. et at. (1996) Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin. Endocrinol., 45, 435-441.
31. Mendelsohn, M.E. and Karas, R.H. (1999) The protective effects of estrogen on the cardiovascular system. N Engl J. Med, 340, 1801-1811.
32. Palmer, J.R., Rosenberg, L. and Shapiro, S. (1992) Reproductive factors and risk of myocardial infarction. Am. J. Epidemiol., 136, 408-416.
33. Perez Gutthann, S., Rodriguez L.A., Castellssague, J. and Duque Oliart, A. (1997) Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. Br. Med. J., 314, 796-800.
34. Petitti, D.B. (1998) Hormone replacement therapy and heart disease prevention. Experimentation trumps observation. JAMA, 280, 650-652.
35. Pike, M.C. (1987) Age-related factors in cancers of the breast, ovary, and endometrium. J. Chron. Dis., 40, Suppl. 2, 59S-69S.
36. Pike, M.C., Ross, R.K. and Spicer, D.V. (1998) Problems involved including women with simple hysterectomy in epidemiologic studies measuring the effect of hormone replacement therapy on breast cancer risk. Am. J. Epidemiol., 147, 718-721.
37. Rosenberg, L., Shapiro, S., Kaufman, D.W. et al. (1979) Patterns and determinants of conjugated estrogen use. Am. J. Epidemiol., 109, 676-686.
38. Rosenberg L., Miller D.R., Kaufman, D.W. et al. (1983) Myocardial infarction in women under 50 years of age. JAMA, 250, 2801-2806.
39. Schaefer, E.J., Lamon-Fava, S., Cohn, S.D. et al. (1994) Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res., 35, 779-792.
40. Stampfer, M.J., Colditz, G.A., Willett, W.C. et al. (1991) Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med., 325, 756-762.
41. The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 273, 199-208. [Published erratum appears in (1995) JAMA, 274, 1676].
42. World Health Organization. (1971) Ischemic heart disease registers; report of the Fifth Working Group. WHO, Copenhagen.